NCT00600886 - Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly | Biotech Hunter

Enrollment

358

Participants

Timeline

Start Date

February 11, 2008

Primary Completion Date

March 11, 2016

Study Completion Date

March 11, 2016

Conditions

Acromegaly

Interventions

DRUG

Pasireotide

Pasireotide LAR - intramuscular (i.m.) depot injection given once every 28 days.

DRUG

Octreotide

Octreotide LAR - i.m. depot injection given once every 28 days.

Trial Locations (95)

1070

Novartis Investigative Site, Brussels

1085

Novartis Investigative Site, Budapest

1090

Novartis Investigative Site, Brussels

3000

Novartis Investigative Site, Leuven

9000

Novartis Investigative Site, Ghent

9007

Novartis Investigative Site, Sankt Gallen

10002

Novartis Investigative Site, Taipei

10032

Columbia University Medical Center- New York Presbyterian Dept. of CU Collegeof Phys&Sur, New York

10098

Novartis Investigative Site, Berlin

10126

Novartis Investigative Site, Torino

11768

Northport VA Medical Center CSOM230C2305, Northport

12203

Novartis Investigative Site, Berlin

13385

Novartis Investigative Site, Marseille

15212

Allegheny Endocrinology Associates, Pittsburgh

15706

Novartis Investigative Site, Santiago de Compostela

16132

Novartis Investigative Site, Genova

18537

Novartis Investigative Site, Piraeus

21205

Johns Hopkins University School of Medicine Dept.ofJohnsHopkinsUniv., Baltimore

25240

Novartis Investigative Site, Erzurum

32610

University of Florida SC, Gainesville

33305

Novartis Investigative Site, Linkou District

33604

Novartis Investigative Site, Pessac

34295

Novartis Investigative Site, Montpellier

35128

Novartis Investigative Site, Padua

40705

Novartis Investigative Site, Taichung

41013

Novartis Investigative Site, Seville

44100

Novartis Investigative Site, Cona

45122

Novartis Investigative Site, Essen

49100

Novartis Investigative Site, Petah Tikva

56124

Novartis Investigative Site, Pisa

69677

Novartis Investigative Site, Bron

75014

Novartis Investigative Site, Paris

75390

University of Texas Southwestern Medical Center Danziger Research Bldg., Dallas

76233

Novartis Investigative Site, Bois-Guillaume

77030

Baylor College of Medicine, Houston

80131

Novartis Investigative Site, Napoli

80336

Novartis Investigative Site, München

90048

Cedars Sinai Medical Center The Pituitary Center, Los Angeles

90095

University of California at Los Angeles Division of Endocrinology, Los Angeles

91054

Novartis Investigative Site, Erlangen

91120

Novartis Investigative Site, Jerusalem

94275

Novartis Investigative Site, Le Kremlin-Bicêtre

94304

Stanford University Medical Center Stanford Cancer Center (3), Stanford

97201

Oregon Health & Sciences University DeptofOregonHealth&Sciences(3), Portland

100730

Novartis Investigative Site, Beijing

111411

Novartis Investigative Site, Bogota

117036

Novartis Investigative Site, Moscow

119992

Novartis Investigative Site, Moscow

194044

Novartis Investigative Site, Saint Petersburg

197341

Novartis Investigative Site, Saint Petersburg

200025

Novartis Investigative Site, Shanghai

48109-0944

University of Michigan Comprehensive Cancer Center Deptof Endocrinology&Diabetes, Ann Arbor

77030-4009

University of Texas/MD Anderson Cancer Center Regulatory -12, Houston

Unknown

Swedish Medical Center Dept.ofSeattle Neuroscience(2), Seattle

C1405BCH

Novartis Investigative Site, CABA

1425EKP

Novartis Investigative Site, Capital Federal

C1232AAC

Novartis Investigative Site, Buenos Aires

60430 370

Novartis Investigative Site, Fortaleza

70840-901

Novartis Investigative Site, Brasília

65020-070

Novartis Investigative Site, São Luís

80060-900

Novartis Investigative Site, Curitiba

21941-913

Novartis Investigative Site, Rio de Janeiro

05403-000

Novartis Investigative Site, São Paulo

T6G 2B7

Novartis Investigative Site, Edmonton

V5Z 1M9

Novartis Investigative Site, Vancouver

B3H 2Y9

Novartis Investigative Site, Halifax

H2L 2W5

Novartis Investigative Site, Montreal

J1H 5N4

Novartis Investigative Site, Sherbrooke

128 02

Novartis Investigative Site, Prague

DK-9100

Novartis Investigative Site, Aalborg

DK-2100

Novartis Investigative Site, Copenhagen

115 27

Novartis Investigative Site, Athens

00168

Novartis Investigative Site, Roma

06720

Novartis Investigative Site, Mexico City

06726

Novartis Investigative Site, Mexico City

6525 GA

Novartis Investigative Site, Nijmegen

3015 CE

Novartis Investigative Site, Rotterdam

NO-5021

Novartis Investigative Site, Bergen

NO-0379

Novartis Investigative Site, Oslo

31-531

Novartis Investigative Site, Krakow

01 809

Novartis Investigative Site, Warsaw

03722

Novartis Investigative Site, Seoul

05505

Novartis Investigative Site, Seoul

06351

Novartis Investigative Site, Seoul

130-872

Novartis Investigative Site, Seoul

08907

Novartis Investigative Site, L'Hospitalet de Llobregat

03010

Novartis Investigative Site, Alicante

SE-581 85

Novartis Investigative Site, Linköping

SE-205 02

Novartis Investigative Site, Malmo

SE-751 85

Novartis Investigative Site, Uppsala

06100

Novartis Investigative Site, Ankara

LS1 3EX

Novartis Investigative Site, Leeds

L7 8XP

Novartis Investigative Site, Liverpool

EC1A 7BE

Novartis Investigative Site, London

SO16 6YD

Novartis Investigative Site, Southampton